Projected Growth of the Global Animal Biotechnology Market to Reach $48.36 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the animal biotechnology market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Animal Biotechnology Market By The End Of 2029?

The scope of the animal biotechnology sector has seen considerable expansion throughout the past few years, projected to increase from a valuation of $30.33 billion in 2024 to $32.89 billion the following year, reflecting an 8.5% compound annual growth rate. This historical upward trajectory is underpinned by several crucial factors, including advancements in genetic enhancement, boosts in farm output efficiency, the development of vaccines and medicinal treatments tailored for animals, a focus on achieving greater ecological sustainability, improvements in how efficiently feed is utilized, enhancements in animal nutrition, and efforts to lessen the sector’s ecological footprint.

Anticipation surrounds the domain of animal biotechnology, projecting substantial expansion in the near future, with its market valuation set to reach $48.36 billion by the year 2029, fueled by a compound annual growth rate (CAGR) of 10.1%; this forthcoming upward trajectory is underpinned by several key factors, including progress in creating strains resilient to illness, the expanding role of biopharmaceutical manufacturing, the rising field of cultured meat creation, anxieties pertaining to worldwide food supply stability, favorable governmental oversight, and increasing endorsement from the general public and consumers, while significant movements shaping this period involve advancements in genomic alteration techniques (mentioned twice to maintain data structure), progress in animal stem cell applications, the utilization of animals for producing biopharmaceuticals, efforts in biobanking and safeguarding genetic resources, the introduction of therapeutic solutions based on Crispr methodology, and stronger emphasis on biosecurity measures alongside disease monitoring.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8059&type=smp

Which Business Drivers Are Underpinning The Growth Of The Animal Biotechnology Market?

Increased consciousness surrounding the well-being and proper treatment of animals is anticipated to be a major catalyst for the expansion of the animal biotechnology sector in the future. Animal welfare and health pertain to the manner in which humans engage with animals and the duty they bear to guarantee that creatures under their supervision receive humane and suitable management. Within the realm of animal health and welfare, biotechnological advancements contribute to enhanced animal productivity by optimizing aspects such as growth rates, reproductive success, nutritional content, feed conversion efficiency, and food security, thereby leading to more effective resource deployment. As an illustration, the Humane Society initiated its More Than a Pet campaign in May 2023, highlighting the necessity of fair access to veterinary services, especially for populations facing limited resources. This program facilitated care for more than 14,800 companions throughout 2023, supplying 64,000 procedures through local outreach efforts designed to elevate animal welfare standards in economically disadvantaged locales, concentrating on delivering crucial veterinary attention and aid to boost the condition of animals residing in areas with few resources, consequently underpinning the link between heightened animal welfare awareness and the surging momentum of the animal biotechnology market.

What Are The Principal Segment Types In The Animal Biotechnology Market?

The animal biotechnology market covered in this report is segmented –

1) By Product Type: Diagnostics Tests, Vaccines, Drugs, Reproductive And Genetic, Feed Additives

2) By Animal Type: Companion, Livestock

3) By Application: Diagnosis Of Animal Diseases, Treatment Of Animal Diseases, Preventive Care Of Animals, Drug Development, Other Applications

4) By End-Use: Laboratories, Point-Of-Care Testing Or In-house Testing, Veterinary Hospitals And Clinics, Other End-Uses

Subsegments:

1) By Diagnostics Tests: Immunodiagnostic Tests, Molecular Diagnostic Tests, Biochemical Diagnostic Tests

2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

3) By Drugs: Antimicrobial Drugs, Anti-Inflammatory Drugs, Hormonal Drugs

4) By Reproductive And Genetic: Genetic Testing Services, Artificial Insemination Products, Embryo Transfer Technologies

5) By Feed Additives: Probiotics, Enzymes, Nutraceuticals

How Are Industry Trends Steering The Expansion Of The Animal Biotechnology Market?

A significant trend impacting the animal biotechnology sector revolves around advancements in product innovation, with leading companies directing substantial resources toward pioneering offerings such as utilizing virus-like particle (VLP) technology for creating vaccines. Illustratively, in April of 2022, the Indian multinational pharmaceutical firm, Cadila Pharmaceuticals, released ThRabis, a three-injection rabies vaccine formulated employing virus-like particle methodology against the rabies virus. The approach known as Virus-Like Particles (VLPs) involves a vaccine creation method utilizing complex protein structures meticulously designed to replicate the physical characteristics, including shape and dimension, of an actual virus particle, yet these structures are deliberately devoid of the viral genetic material, thereby potentially resulting in vaccine options that are both more secure and more economical to produce. Specifically, ThRabis incorporates a recombinant nanoparticle-based rabies G protein; this component stimulates the body to produce antibodies specifically targeting the rabies G protein, which subsequently function to neutralize the virus and obstruct its ability to bind to host cells, ultimately conferring protective immunity against rabies infection.

Which Companies Are Contributing Significantly To The Animal Biotechnology Market Growth?

Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Santé Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

Which Region Offers The Most Opportunity For Animal Biotechnology Market Expansion?

North America was the largest region in the animal biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8059&type=smp

Browse Through More Reports Similar to the Global Animal Biotechnology Market 2025, By The Business Research Company

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Pain Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795